261 related articles for article (PubMed ID: 11105899)
1. Alterations of the AML1 transcription factor in human leukemia.
Downing JR; Higuchi M; Lenny N; Yeoh AE
Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
[TBL] [Abstract][Full Text] [Related]
2. The role of the AML1 transcription factor in leukemogenesis.
Lorsbach RB; Downing JR
Int J Hematol; 2001 Oct; 74(3):258-65. PubMed ID: 11721960
[TBL] [Abstract][Full Text] [Related]
3. New mechanisms of AML1 gene alteration in hematological malignancies.
Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
[TBL] [Abstract][Full Text] [Related]
4. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
5. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
6. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
Zent C; Rowley JD; Nucifora G
Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
[TBL] [Abstract][Full Text] [Related]
7. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
[TBL] [Abstract][Full Text] [Related]
8. AML1 interconnected pathways of leukemogenesis.
Michaud J; Scott HS; Escher R
Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014
[TBL] [Abstract][Full Text] [Related]
9. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
[TBL] [Abstract][Full Text] [Related]
10. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
[TBL] [Abstract][Full Text] [Related]
11. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
Kurokawa M; Hirai H
Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
[TBL] [Abstract][Full Text] [Related]
12. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
13. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
Nimer SD; Moore MA
Oncogene; 2004 May; 23(24):4249-54. PubMed ID: 15156180
[TBL] [Abstract][Full Text] [Related]
14. E protein silencing by the leukemogenic AML1-ETO fusion protein.
Zhang J; Kalkum M; Yamamura S; Chait BT; Roeder RG
Science; 2004 Aug; 305(5688):1286-9. PubMed ID: 15333839
[TBL] [Abstract][Full Text] [Related]
15. CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors.
D'Costa J; Chaudhuri S; Civin CI; Friedman AD
Leukemia; 2005 Jun; 19(6):921-9. PubMed ID: 15815715
[TBL] [Abstract][Full Text] [Related]
16. Core-binding factor: a central player in hematopoiesis and leukemia.
Speck NA; Stacy T; Wang Q; North T; Gu TL; Miller J; Binder M; Marín-Padilla M
Cancer Res; 1999 Apr; 59(7 Suppl):1789s-1793s. PubMed ID: 10197598
[TBL] [Abstract][Full Text] [Related]
17. AML1 and AML1 fusion protein AML1-ETO in myeloid gene regulation and leukemogenesis.
Zhang DE; Burel S; Zhou L; Hetherington CJ; Yuan Y
Blood Cells Mol Dis; 2001; 27(2):368-76. PubMed ID: 11259158
[No Abstract] [Full Text] [Related]
18. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
Zhang Y; Emmanuel N; Kamboj G; Chen J; Shurafa M; Van Dyke DL; Wiktor A; Rowley JD
Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
[TBL] [Abstract][Full Text] [Related]
19. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
Tsuzuki S; Seto M; Greaves M; Enver T
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
